McKesson competitors

Mark T. Bertolini (born 1956) is an American businessman who was the CEO of Aetna, a Fortune 50 diversified health care benefits company with over $60 billion in 2015 revenue. Bertolini assumed the role of CEO on November 29, 2010 and of Chairman on April 8, 2011 until Aetna was sold to CVS on November 28, 2018.

Mike served as Chief Financial Officer and Corporate Executive Vice President of FIS, Fortune 500’s #1 financial technology company, from 2009 until 2013. As the President and Chief Operating Officer of Metavante Technologies, Inc., Mike led the successful completion of Metavante’s merger with FIS to create the world’s largest financial technology company. Mike was instrumental in building Metavante from a $93 million annual revenue company into the global leader of financial technology with over $6 billion of annual revenue. Previously, he served as Metavante’s CIO, CFO, head of product development, and head of corporate development, and he led the company’s successful carve-out from a bank holding company and IPO in 2007. During his tenure, Mike led a significant number of acquisitions, public offerings for equity sales and debt raising, and led teams to innovate and build technology. Mike is a Director of Endurance International Group Holdings, Inc. and has served on the Board of West Bend Mutual Insurance Company, for which he chairs the Audit Committee. Mike is a Certified Public Accountant and holds a Master Degree in Business Administration from Northwestern University’s Kellogg School of Business and a B.S. in Accounting and Computer Science from the University of Wisconsin.

Ed was named president & chief executive officer of Owens & Minor, effective March 7, 2019, and was appointed to the board of directors at the same time. Prior to that, Ed served as an independent consultant and advisor in the healthcare, life science and distribution industries since January 2016. From January 2000 through April 2015, he served in various roles of increasing responsibility at Thermo Fisher Scientific, a $17 billion manufacturer and supplier of a range of products to the research, healthcare, industrial and safety markets, including most recently as chief commercial officer & senior vice president. Before joining Thermo Fisher Scientific, Ed spent eight years at TRW Inc., in a variety of finance roles and three years with PricewaterhouseCoopers as an auditor.